-- New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte's (PCVX) PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations -- -- Expanded Collaboration Builds on ...
To lead this work, the state has engaged some of the nation’s leading public health voices, including Dr. Susan Monarez, former Director of the Centers for Disease Control and Prevention; Dr. Debra ...
SAN CARLOS, Calif. and BASEL, Switzerland, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback